AI pathology study for solid tumor patients
Part of Cancer, Skin clinical trials.
This study collects real-world data from patients with solid tumors whose tissue samples are tested using an AI-based pathology tool. It aims to link the AI results with patient outcomes to improve cancer care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a solid tumor cancer, confirmed by a biopsy or cell sample.
- You are having an Ataraxis test as part of your regular cancer care.
- A sample of your tumor tissue is available for testing.
- You can understand and sign a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to analyze images of your tumor tissue to predict if breast cancer might spread to other parts of the body. It may help doctors better understand your individual risk and guide treatment decisions.
This trial tests a non-invasive, AI-based monitoring program for people with solid tumors. It aims to help track how you’re doing during or after curative-intent treatment, using information collected without extra procedures.
This study uses artificial intelligence to analyze tissue samples from breast cancer that has spread to distant organs, like the liver or lungs. The goal is to develop a tool that predicts how breast cancer might spread, helping doctors personalize treatment.
This study tests whether an AI tool can predict how well breast cancer responds to chemotherapy given before surgery. Your tumor sample from a needle biopsy will be analyzed to see if the AI's prediction matches your actual treatment outcome.
This study uses artificial intelligence to look at CT scans you've already had (without dye) to try and find signs of several types of cancer early. It may help find cancer sooner when it's easier to treat.
This trial uses artificial intelligence to analyze CT and MRI scans of solid tumors. The goal is to better understand how tumors respond to non-surgical treatments, which could help doctors make more personalized treatment decisions.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.